ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1854

Increased Percentage of CD204/CD206 Double Positive Monocytes Correlates with Specific Lung and Skin Involvement Parameters and an “Active” Capillaroscopic Pattern of Microangiopathy in Systemic Sclerosis Patients

Stefano Soldano1, Paola Contini2, Amelia Chiara Trombetta3, Barbara Ruaro4, Sabrina Paolino4, Carmen Pizzorni4, Renata Brizzolara4, Paola Montagna4, Alberto Sulli4 and Maurizio Cutolo4, 1Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genoa, Italy, Genoa, Italy, 2Division of Clinical Immunology, Department of Internal Medicine, University of Genova, Genoa, Italy, Genova, Italy, 3Department of Internal Medicine, University of Genova,, Research Laboratory and Academic Division of Clinical Rheumatology, Genova, Italy, 4Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genoa, Italy, Genova, Italy

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Macrophage, monocytes and systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Pathogenesis, Animal Models and Genetics - Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Immune cell activation plays a crucial role in the pathogenesis of systemic sclerosis (SSc), and macrophages may be important mediators in this complex pathway (1,2). In SSc patients (pts), alternatively activated macrophages (M2) are present in the skin infiltrate, contributing to dermal fibrosis (2). M2 may differentiate from peripheral blood monocytes (PBMs), and are characterized by the expression of specific phenotype markers, such as CD206 (mannose receptor-1), and CD204 (macrophage scavenger receptor) (1). The study investigated the percentages of circulating CD206+/CD204+PBMs in SSc pts and possible correlations with specific clinical parameters.

Methods:  Sera from forty-one SSc pts (36 females/5 males, mean age 62±15 years), who fulfilled the new EULAR/ACR criteria (3), and twenty voluntary healthy subjects (HS – 16 females/4 males, 61±10 years) were collected after EC approval and Informed Consent signed. Lung involvement (DLCO) and specific SSc autoantibodies (anti-centromere/CENP; anti-topoisomerase/Scl70; RNApoly3; fibrillarin; Th/Th0; PM-Scl75) were analysed. Nailfold videocapillaroscopy (NVC) was performed to define the pattern of microangiopathy. PBMs from SSc pts and HS were evaluated by flow cytometry (FC) by investigating cell positive for CD14 (monocyte/macrophage marker), CD206 and CD204. The statistical analysis was carried out using Mann-Whitney non-parametric U-test and correlation test.

Results:  Among the 41 SSc pts, 27 showed a “limited” cutaneous involvement (lSSc) and 14 a “diffuse” cutaneous involvement (dSSc). The analysis of specific auto-antibodies yielded 13 pts positive for CENP, 16 pts positive for Scl70, 6 pts positive for the other investigated autoantibodies. Six pts were found Ab negative and excluded from the study. The evaluation by FC of circulating CD14+cells did not show any significant difference between SSc patients and HS. However, in the CD14+cell subset the percentage of CD206+CD204+cells was significantly increased in SSc pts compared to HS (p=0.02). The percentage of these cells was increased in lSSc pts (p=0.06), but significantly increased in dSSc pts (p=0.03) and inversely correlated with DLCO (p=0.032, R=0.13). In addition, CD206+CD204+cells were increased in Scl70-positive pts and significantly increased in CENP positive pts (p=0.011). NVC analysis identified 12 SSc pts with an “early” pattern, 14 pts with an “active” pattern and 16 pts with a “late” pattern. The percentage of CD206+CD204+cells was increased in pts with “early” or “late” NVC pattern (p=0.09, p=0.06) but significantly increased in those with the “active” pattern compared to HS (p=0.04).

Conclusion:  The results confirmed the presence of an increased percentage of cells with an M2 phenotype in the peripheral blood of SSc pts. M2 cells seem to correlate with specific lung and skin involvement, autoantibody positivity and an “active” NVC pattern of microangiopathy. References: 1 Higashi-Kuwata N et al. Arthritis Res Ther 2010:12:R128. 2 Nakayama W et al. Rheumatol Int 2012;32:403–7. 3 van der Hoogen F et al. Arthrit Rheum 2013;65:2737-47.


Disclosure: S. Soldano, None; P. Contini, None; A. C. Trombetta, None; B. Ruaro, None; S. Paolino, None; C. Pizzorni, None; R. Brizzolara, None; P. Montagna, None; A. Sulli, None; M. Cutolo, Actelion, BMS, Sanofi-Aventis, 2,Actelion, BMS, Sanofi-Aventis, 5.

To cite this abstract in AMA style:

Soldano S, Contini P, Trombetta AC, Ruaro B, Paolino S, Pizzorni C, Brizzolara R, Montagna P, Sulli A, Cutolo M. Increased Percentage of CD204/CD206 Double Positive Monocytes Correlates with Specific Lung and Skin Involvement Parameters and an “Active” Capillaroscopic Pattern of Microangiopathy in Systemic Sclerosis Patients [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/increased-percentage-of-cd204cd206-double-positive-monocytes-correlates-with-specific-lung-and-skin-involvement-parameters-and-an-active-capillaroscopic-pattern-of-microangiopathy-i/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/increased-percentage-of-cd204cd206-double-positive-monocytes-correlates-with-specific-lung-and-skin-involvement-parameters-and-an-active-capillaroscopic-pattern-of-microangiopathy-i/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology